Literature DB >> 18159541

Cardiac device infections due to Mycobacterium fortuitum.

Marion Hemmersbach-Miller1, Miguel A Cárdenes-Santana, Alicia Conde-Martel, José A Bolaños-Guerra, María I Campos-Herrero.   

Abstract

Two cases of cardiac device infection due to Mycobacterium fortuitum are reported along with a discussion of their clinical management. Long-term therapy and removal of the infected device is needed. The slow progression and absence of systemic signs and symptoms suggest a low pathogenicity of M fortuitum.

Entities:  

Keywords:  Cardiac device; Mycobacterium fortuitum

Year:  2005        PMID： 18159541      PMCID： PMC2095021          DOI： 10.1155/2005/175132

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


  11 in total

1.  Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.

Authors:  R J Wallace; G Bedsole; G Sumter; C V Sanders; L C Steele; B A Brown; J Smith; D R Graham
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

2.  Mycobacterium fortuitum complex in Sweden during an 11-year period.

Authors:  A Svahn; S E Hoffner; B Petrini; G Källenius
Journal:  Scand J Infect Dis       Date:  1997

3.  Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.

Authors:  R J Wallace; B A Brown; G O Onyi
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

Review 4.  The clinical use of fluoroquinolones for the treatment of mycobacterial diseases.

Authors:  G J Alangaden; S A Lerner
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

Review 5.  Mycobacterial diseases other than tuberculosis.

Authors:  E Wolinsky
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

6.  Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheters.

Authors:  J F Hoy; K V Rolston; R L Hopfer; G P Bodey
Journal:  Am J Med       Date:  1987-08       Impact factor: 4.965

7.  Infections with rapidly growing mycobacteria: report of 20 cases.

Authors:  Somnuek Sungkanuparph; Boonmee Sathapatayavongs; Roongnapa Pracharktam
Journal:  Int J Infect Dis       Date:  2003-09       Impact factor: 3.623

8.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 9.  Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review.

Authors:  I I Raad; S Vartivarian; A Khan; G P Bodey
Journal:  Rev Infect Dis       Date:  1991 Nov-Dec

10.  Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.

Authors:  B A Brown; R J Wallace; G O Onyi; V De Rosas; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191
View more
  7 in total

1.  Mycobacterium fortuitum infections associated with laparoscopic gastric banding.

Authors:  Erin C Callen; Tiffany L Kessler
Journal:  Obes Surg       Date:  2011-03       Impact factor: 4.129

2.  Failure to recognize nontuberculous mycobacteria leads to misdiagnosis of chronic pulmonary tuberculosis.

Authors:  Mamoudou Maiga; Sophia Siddiqui; Souleymane Diallo; Bassirou Diarra; Brehima Traoré; Yvonne R Shea; Adrian M Zelazny; Bindongo P P Dembele; Drissa Goita; Hamadoun Kassambara; Abdulrahman S Hammond; Michael A Polis; Anatole Tounkara
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

3.  Rapidly growing mycobacteria associated with laparoscopic gastric banding, Australia, 2005-2011.

Authors:  Hugh L Wright; Rachel M Thomson; Alistair B Reid; Robyn Carter; Paul B Bartley; Peter Newton; Christopher Coulter
Journal:  Emerg Infect Dis       Date:  2014-10       Impact factor: 6.883

Review 4.  Cardiac implantable electronic device infection due to Mycobacterium species: a case report and review of the literature.

Authors:  Bandar Al-Ghamdi; Hassan El Widaa; Maie Al Shahid; Mohammed Aladmawi; Jawaher Alotaibi; Aly Al Sanei; Magid Halim
Journal:  BMC Res Notes       Date:  2016-08-24

Review 5.  Patient Report and Review of Rapidly Growing Mycobacterial Infection after Cardiac Device Implantation.

Authors:  Varun K Phadke; David S Hirsh; Neela D Goswami
Journal:  Emerg Infect Dis       Date:  2016-03       Impact factor: 6.883

6.  Native valve endocarditis and pacemaker infection with Mycobacterium fortuitum.

Authors:  Moamen Al Zoubi; Joyce Cheng; Venkate S Dontaraju; Colin E Evans; Addie B Spier
Journal:  IDCases       Date:  2021-06-16

Review 7.  Cardiac resynchronization therapy-defibrillator pocket infection caused by Mycobacterium fortuitum: a case report and review of the literature.

Authors:  Jun Zhu; Qingluan Yang; Junjie Pan; Haiming Shi; Bo Jin; Qiying Chen
Journal:  BMC Cardiovasc Disord       Date:  2019-03-05       Impact factor: 2.298
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.